silybin has been researched along with phosphatidylcholines in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Head, K; Kidd, P | 1 |
| Agarwal, R; Crighton, F; Flaig, TW; Glodé, LM; Gustafson, DL; Harrison, GS; Pierson, AS; Su, LJ; Zirrolli, JA | 1 |
| Filburn, CR; Griffin, DW; Kettenacker, R | 1 |
| Berry, DP; Boocock, DJ; Brown, VA; Cai, H; Gescher, AJ; Hoh, CS; Marczylo, TH; Steward, WP | 1 |
| Brown, K; Gescher, AJ; Steward, WP; Verschoyle, RD | 1 |
| Brown, K; Gescher, AJ; Greaves, P; Marsden, DA; Patel, K; Steward, WP; Verschoyle, RD | 1 |
| McCord, KW; Twedt, DC; Webb, CB | 1 |
| Glushenkov, DV; Maevskaia, MV; Tel'nykh, IuV | 1 |
| Duan, RL; Gong, T; Liu, J; Sun, X; Zhang, ZR | 1 |
| Andreone, P; Brisc, C; Brisc, MC; Bugianesi, E; Chiaramonte, M; Cursaro, C; Danila, M; de Sio, I; Del Vecchio Blanco, C; Federico, A; Floreani, A; Freni, MA; Grieco, A; Groppo, M; Lazzari, R; Lobello, S; Loguercio, C; Lorefice, E; Margotti, M; Miele, L; Milani, S; Okolicsanyi, L; Palasciano, G; Portincasa, P; Saltarelli, P; Smedile, A; Somalvico, F; Sorrentino, P; Spadaro, A; Sporea, I; Tuccillo, C; Vecchione, R | 1 |
| Flaig, TW; Goyal, A; Greenlee, H; Gustafson, DL; Hansen, RJ; Jacobson, JS; Kelly, K; Ladas, E; Lee, V; Lunghofer, PJ; Narayan, R; Rodriguez, R; Siegel, AB; Tsai, WY; Wu, DP | 1 |
| Chen, L; Li, Y; Shen, J; Xu, P; Yin, Q; Yu, H; Zhang, Z | 1 |
| Abenavoli, L; Accattato, F; Foti, D; Greco, M; Gulletta, E; Luzza, F; Milic, N; Nazionale, I; Peta, V | 1 |
| Aristarco, V; Bonanni, B; Caldarella, P; Cazzaniga, M; DeCensi, A; Gandini, S; Guerrieri-Gonzaga, A; Johansson, H; Lazzeroni, M; Mora, S; Morazzoni, P; Pagani, G; Petrangolini, G; Pruneri, G; Puccio, A; Riva, A; Serrano, D | 1 |
| Dibildox-Martinez, M; Flores-Murrieta, FJ; Méndez-Sánchez, N; Sánchez-Medal, R; Sosa-Noguera, J | 1 |
1 review(s) available for silybin and phosphatidylcholines
| Article | Year |
|---|---|
A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
Topics: Animals; Biological Availability; Drug Combinations; Humans; Liver; Liver Diseases; Phosphatidylcholines; Phytotherapy; Rats; Silybin; Silybum marianum; Silymarin | 2005 |
8 trial(s) available for silybin and phosphatidylcholines
| Article | Year |
|---|---|
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.
Topics: Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Excipients; Follow-Up Studies; Gastrointestinal Diseases; Glucuronides; Humans; Liver Function Tests; Male; Phosphatidylcholines; Prostatic Neoplasms; Silybin; Silymarin; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2007 |
Bioavailability of a silybin-phosphatidylcholine complex in dogs.
Topics: Administration, Oral; Animals; Antioxidants; Area Under Curve; Biological Availability; Dogs; Female; Male; Phosphatidylcholines; Phytotherapy; Plant Extracts; Silybin; Silymarin | 2007 |
[The use of hepatoprotector LiverPro in combined therapy of chronic viral hepatitis C].
Topics: Adult; Antiviral Agents; Drug Combinations; Drug Therapy; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver; Male; Phosphatidylcholines; Silybin; Silymarin; Young Adult | 2008 |
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
Topics: Body Mass Index; Fatty Liver; Humans; Phosphatidylcholines; Romania; Silybin; Silymarin; Vitamin E | 2012 |
A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma.
Topics: Antioxidants; Carcinoma, Hepatocellular; Disease Progression; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Phosphatidylcholines; Silybin; Silybum marianum; Silymarin | 2014 |
Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease.
Topics: Adult; Biomarkers; Body Mass Index; Cholesterol; Diet, Mediterranean; Dietary Supplements; Humans; Italy; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Overweight; Phosphatidylcholines; Prospective Studies; Silybin; Silymarin; Time Factors; Treatment Outcome; Triglycerides; Vitamin E; Waist Circumference | 2015 |
A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer.
Topics: Administration, Oral; Antineoplastic Agents; Biological Availability; Biomarkers, Tumor; Breast Neoplasms; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydrolysis; Middle Aged; Phosphatidylcholines; Reproducibility of Results; Silybin; Silymarin; Tandem Mass Spectrometry | 2016 |
Superior silybin bioavailability of silybin-phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers.
Topics: Administration, Oral; Adult; Biological Availability; Capsules; Cross-Over Studies; Female; Gels; Healthy Volunteers; Humans; Male; Phosphatidylcholines; Silybin; Single-Blind Method; Tablets; Young Adult | 2019 |
6 other study(ies) available for silybin and phosphatidylcholines
| Article | Year |
|---|---|
Quantitation of silibinin, a putative cancer chemopreventive agent derived from milk thistle (Silybum marianum), in human plasma by high-performance liquid chromatography and identification of possible metabolites.
Topics: Anticarcinogenic Agents; Chromatography, High Pressure Liquid; Humans; Phosphatidylcholines; Silybin; Silybum marianum; Silymarin; Stereoisomerism | 2007 |
Consumption of silibinin, a flavonolignan from milk thistle, and mammary cancer development in the C3(1) SV40 T,t antigen transgenic multiple mammary adenocarcinoma (TAg) mouse.
Topics: Animals; Antigens, Polyomavirus Transforming; Female; Flavonolignans; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Molecular Structure; Phosphatidylcholines; Silybin; Silybum marianum; Silymarin; Stereoisomerism | 2008 |
Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels.
Topics: Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Chromatography, High Pressure Liquid; Drug Evaluation; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Prostatic Neoplasms; Silybin; Silymarin | 2008 |
Assessment of oxidative stress in leukocytes and granulocyte function following oral administration of a silibinin-phosphatidylcholine complex in cats.
Topics: Animals; Antioxidants; Cats; Female; Flow Cytometry; Glutathione; Glutathione Peroxidase; Granulocytes; Leukocytes; Male; Oxidative Stress; Phagocytosis; Phosphatidylcholines; Respiratory Burst; Silybin; Silymarin; Superoxide Dismutase | 2009 |
Mixed micelles loaded with silybin-polyene phosphatidylcholine complex improve drug solubility.
Topics: Animals; Antioxidants; Bile Acids and Salts; Calorimetry, Differential Scanning; Infusions, Intravenous; Micelles; Particle Size; Phosphatidylcholines; Rats; Silybin; Silybum marianum; Silymarin; Solubility | 2011 |
Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.
Topics: Animals; Antineoplastic Agents; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Drug Synergism; Female; Humans; Lung Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Nude; Nanoparticles; Neoplasm Invasiveness; Particle Size; Phosphatidylcholines; Polyethylene Glycols; Silybin; Silymarin; Snail Family Transcription Factors; Solubility; Technology, Pharmaceutical; Time Factors; Tissue Distribution; Transcription Factors; Vitamin E; Wound Healing; Xenograft Model Antitumor Assays | 2013 |